Psoriasis Life Expectancy Calculator
Psoriasis is a chronic inflammatory condition that goes well beyond the skin, and people with severe disease do lose some years of life on average, mostly through cardiovascular disease, diabetes and other comorbidities. This calculator gives a rough, scenario-based estimate: enter age, gender, psoriasis severity, comorbidities and treatment status, and it shows an adjusted life-expectancy figure plus years remaining. It is an illustration built on simple arithmetic, not a medical prediction, and nothing here replaces a clinician’s assessment.
This is an illustrative estimate from a simplified model, not a medical prediction. Individual outcomes vary widely. Discuss your personal outlook with a healthcare professional.
Quick Answer
With the pre-filled values, a 55-year-old woman with moderate psoriasis, diabetes and well-managed treatment gets an estimated life expectancy of 77.0 years, or 22.0 years remaining. The arithmetic: 81 − 2 (moderate) − 4 (diabetes) + 2 (managed) = 77.0, then 77.0 − 55 = 22.0. Click Calculate life expectancy to reproduce it. Treat the figure as an illustration of how the inputs move together, not a forecast of your own lifespan.
Key takeaways
- Research finds people diagnosed with psoriasis at 40 lose roughly 2 years of life expectancy on average; for generalized pustular psoriasis the loss is around 18-19 years.
- Mild psoriasis shows little to no significant reduction in life expectancy in large cohort studies; the mortality burden concentrates in moderate-to-severe disease and its comorbidities.
- The calculator below is a simplified scenario model with illustrative adjustments, not an epidemiological prediction. Its baselines roughly match US average life expectancy at birth (about 81 female, 76 male).
- Whatever the estimate says, the actionable part is the same: manage the psoriasis, screen for cardiovascular disease and diabetes, and discuss personal risk with a clinician.
- Quick Answer
- How to use the psoriasis life expectancy calculator
- How the estimate is built, with nothing hidden
- Worked example: the pre-filled scenario, checked
- What the research actually says about psoriasis and lifespan
- Honest limits of this tool
- What competing calculators miss
- Frequently asked questions
- Add This Calculator to Your Website
- References
How to use the psoriasis life expectancy calculator
Fill in five inputs, click Calculate life expectancy, and read two numbers. The results stay hidden until you calculate, and Reset restores the worked example.
- Enter your current age: a whole number between 0 and 120. Anything else shows "Please enter a valid age" instead of a guess.
- Select gender, severity, comorbidities and treatment status: the tooltips on each label spell out exactly what the choice adds or subtracts, so there is no hidden arithmetic.
- Click Calculate life expectancy: the tool shows the estimated life expectancy in large type and the years remaining underneath. Years remaining can never go below zero.
- Change one input at a time: switching treatment from unmanaged to well managed, for example, moves the estimate by 3 years, which makes the model's sensitivity to each factor visible.
How the estimate is built, with nothing hidden
The tool starts from a baseline, 81 years for female and 76 years for male, roughly the US average life expectancy at birth reported by the CDC, then applies fixed adjustments. These adjustments are illustrative weights, not clinical coefficients: no cohort study produced the figure "-4 years for diabetes" inside a psoriasis calculator.
Severity: mild −0.5, moderate −2, severe −4 | Comorbidity: cardiovascular −5, diabetes −4, multiple −8
Treatment: well managed +2, partially managed +0.5, unmanaged −1 | Years remaining = max(0, estimate − age)
That candor matters because the weights only approximate real epidemiology. The 2026 England population cohort study of 343,583 people with psoriasis found an 18% higher all-cause mortality (adjusted hazard ratio 1.18) versus matched comparators, translating to about 2 years of life lost for a diagnosis at 40. A Taiwan nationwide cohort reported mean losses of life expectancy of about 6.4 years among patients with moderate-to-severe disease, with loss concentrated in the young. The model's fixed subtractions gesture at those findings without claiming to reproduce them.
Worked example: the pre-filled scenario, checked
The pre-filled inputs are a 55-year-old woman with moderate psoriasis, diabetes and well-managed treatment. The tool computes 81 − 2 − 4 + 2 = 77.0 years, and 77.0 − 55 = 22.0 years remaining. Every row below is a real run of this calculator, reproducible to the decimal.
| Scenario | Life expectancy | Years remaining |
|---|---|---|
| Female, 55, moderate, diabetes, managed | 77.0 years | 22.0 years |
| Male, 40, mild, none, managed | 77.5 years | 37.5 years |
| Male, 60, severe, multiple, unmanaged | 63.0 years | 3.0 years |
| Female, 80, severe, cardiovascular, unmanaged | 71.0 years | 0.0 years (floored) |
What the research actually says about psoriasis and lifespan
Psoriasis itself is rarely fatal, but severe disease shortens average lifespan through systemic inflammation and its comorbidities. The mortality burden is concentrated, not evenly spread: large studies keep finding that mild psoriasis barely registers while severe disease carries a clear signal.
| Study | Finding |
|---|---|
| England CPRD cohort, 2026 (n = 343,583) | Diagnosis at 40 associated with about 2 years of life lost (2.5 in males, 2.0 in females); generalized pustular psoriasis lost about 18.6 years |
| Taiwan nationwide cohort, 2000-2017 | Moderate-to-severe psoriasis: mean loss of life expectancy 6.41 years, greatest in the youngest patients; mild psoriasis did not differ significantly from the general population |
| National Psoriasis Foundation surveys, 2003-2011 | Severe vs mild psoriasis: adjusted odds of psoriatic arthritis 2.32, diabetes 1.5, cardiovascular disease 1.5 |
| AAD/NPF guidelines | Recommend a 1.5x multiplier on cardiovascular risk scores for psoriasis with body surface area over 10%; psoriasis is an official cardiovascular risk enhancer |
The comorbidity story is why the calculator's comorbidity input moves the estimate more than severity does. The National Psoriasis Foundation clinical consensus lists psoriatic arthritis, cardiovascular disease, hypertension, diabetes, obesity and depression as conditions dermatologists should screen for, and cardiovascular disease is the leading cause of the excess mortality in every major cohort. The England study's cause-of-death ranking, respiratory and circulatory diseases first, points the same way.
Honest limits of this tool
An honest calculator says what it cannot do. This one cannot predict your lifespan, and it does not try to: it shows how a handful of risk factors move a rough estimate up or down so you can see which levers are largest.
- Simplified model, illustrative weights: the subtractions for severity and comorbidities are fixed scenario weights, not coefficients fitted to any cohort. Real risk depends on blood pressure, lipids, smoking, weight, family history and dozens of other factors the tool never asks about.
- Binary gender only: the baseline offers male and female, matching the published life tables the anchors come from, but it will not fit everyone.
- No BMI, smoking or activity inputs: the previous version of this page's text described those inputs, but they never existed in the tool, and adding them would change what the tool is. They are noted here as a future enhancement, not promised.
- Not medical advice: use the estimate as a prompt for a conversation with your clinician, especially about cardiovascular and diabetes screening, not as a verdict.
If your main interest is a habits-based estimate rather than a disease-specific one, the average life expectancy calculator models smoking, diet, exercise and BMI instead. Related disease-specific tools include the blood pressure life expectancy calculator and the bipolar life expectancy calculator, each built on different risk models.
What competing calculators miss
There is no widely used psoriasis-specific life expectancy tool to benchmark against, which is itself the finding. The landscape splits into three camps:
- General life expectancy calculators: habits-based models (smoking, alcohol, exercise, diet, BMI) that know nothing about inflammatory disease. They answer a different question: lifestyle risk, not disease risk. Our own average life expectancy calculator is that tool, kept separate on purpose.
- Disease-specific estimators on other sites: blood pressure and similar single-factor tools exist, but none model psoriasis severity, its specific comorbidity pattern (cardiovascular, diabetes) and treatment status together.
- Research papers: the actual epidemiology (Global Psoriasis Atlas, the Taiwan and England cohorts) is rigorous but not interactive. You cannot plug your own numbers into a PDF.
- The gap this page fills: the only interactive estimator that takes psoriasis severity, the comorbidities the literature actually links to psoriasis, and treatment status as inputs, anchored to published years-of-life-lost figures, with the model's simplifications stated on the page instead of hidden.
Frequently asked questions
On average, yes, but modestly and mostly through comorbidities. A 2026 England cohort of 343,583 people found a psoriasis diagnosis at age 40 associated with about 2 years of life lost; mild psoriasis showed little to no significant effect, while generalized pustular psoriasis lost about 18.6 years.
Large cohort studies suggest very little. In the Taiwan nationwide cohort, survival in mild psoriasis did not differ significantly from the general population; the mortality signal concentrates in moderate-to-severe disease and its comorbidities.
Cardiovascular disease and diabetes. Compared with mild psoriasis, severe psoriasis carries about 1.5 times the adjusted odds of each, plus 2.32 times the odds of psoriatic arthritis, and cardiovascular disease is the leading cause of excess mortality in the major cohorts.
Treating psoriasis and its comorbidities is the actionable part of every study cited here, but no study measured years gained by "well managed" treatment directly. The calculator's +2 year treatment adjustment is an illustrative weight, so read it as direction, not measurement.
Its baselines come from published life tables reported by sex, about 81 years for females and 76 years for males in recent US data. The binary input matches those tables; it is a limitation of the model, stated openly.
No. It is an illustrative scenario model with simplified weights, not a clinical prediction. Use it to see which factors move the estimate most, then discuss your personal outlook, especially cardiovascular and diabetes screening, with a healthcare professional.
General calculators model lifestyle factors such as smoking, diet, exercise and BMI. This one models psoriasis severity, its specific comorbidity pattern and treatment status. The two answer different questions and complement each other.
If your age is already above the estimated life expectancy, the tool shows 0.0 years remaining rather than a negative number. It is a display floor in the arithmetic, not a statement about anyone's future.
Add This Calculator to Your Website
Embed this calculator on your own site with the code below. Pick a size to preview it live, then copy the code.
Powered by Calculator Zilo
References
- Global Psoriasis Atlas / British Association of Dermatologists. Life Expectancy, All-Cause Mortality and Cause-Specific Mortality in Psoriasis and Generalized Pustular Psoriasis: A Population-Based Cohort Study in England (2026 poster). Accessed October 23, 2026.
- British Journal of Dermatology. Life Expectancy, All-Cause Mortality and Cause-Specific Mortality in Psoriasis and Generalized Pustular Psoriasis: Abstract. Accessed October 23, 2026.
- Chen, Y.J. et al. Lifetime Risk, Life Expectancy, Loss-of-Life Expectancy, and Lifetime Healthcare Expenditures for Psoriasis in Taiwan: A Nationwide Cohort Followed from 2000 to 2017, Value in Health Regional Issues. Accessed October 23, 2026.
- Kimball, A.B. et al. National Psoriasis Foundation Clinical Consensus on Psoriasis Co-morbidities and Recommendations for Screening, Journal of the American Academy of Dermatology. Accessed October 23, 2026.
- Armstrong, A.W., Schupp, C. and Bebo, B. Psoriasis Comorbidities: Results from the National Psoriasis Foundation Surveys 2003 to 2011, Dermatology. Accessed October 23, 2026.
- Menter, A. et al. Joint American Academy of Dermatology-National Psoriasis Foundation Guidelines of Care for the Management of Psoriasis with Systemic Nonbiologic Therapies. Accessed October 23, 2026.
- UPMC / University of Missouri Health Care. More Than Skin Deep: 5 Psoriasis-Related Conditions. Accessed October 23, 2026.
- Centers for Disease Control and Prevention, National Center for Health Statistics. Mortality in the United States, 2023 (NCHS Data Brief No. 521): Life Expectancy Estimates. Accessed October 23, 2026.
- Centers for Disease Control and Prevention, National Center for Health Statistics. Mortality in the United States, 2024 (NCHS Data Brief No. 548): Life Expectancy Estimates. Accessed October 23, 2026.
- GlobalRPH. The Surprising Link Between Psoriasis and Heart Disease: AAD/NPF Cardiovascular Risk Guidance. Accessed October 23, 2026.